Literature DB >> 8598314

rho-Mediated protein tyrosine phosphorylation in lysophosphatidic-acid-induced tumor-cell invasion.

F Imamura1, K Shinkai, M Mukai, K Yoshioka, R Komagome, T Iwasaki, H Akedo.   

Abstract

Rat ascites hepatoma cell (MM1) invade a mesothelial cell monolayer in vitro in assay medium containing serum, but not in serum-free medium. Serum could be completely replaced by 1-oleoyl lysophosphatidic acid (LPA) in inducing invasion. LPA-induced invasion was inhibited by genistein, a tyrosine-kinase inhibitor. Protein tyrosine phosphorylation in response to LPA was thus analyzed in order to determine the molecular mechanism of invasion. LPA of invasion-inducible concentrations evoked a transient increase in tyrosine phosphorylation, mainly of 110- to 130-kDa proteins in MM1 cells but not in mesothelial cells. These concentrations of LPA were over 10 times higher (10 to 25 micron) than those necessary to produce a variety of biological actions, such as tyrosine phosphorylation in fibroblasts, neurite retraction and platelet aggregation. Protein tyrosine phosphorylation and invasion by MM1 cells induced by LPA are largely regulated by rho p21, because both were inhibited by Clostridium botulinum C3 exo-enzyme, which is known to specifically inactivate rho p21. Invasion of MCL by MM1 cells induced by serum and that by B16FE7 cells induced by LPA were inhibited by genistein or C3 as well. By immunoprecipitation, we detected p 125 focal adhesion kinase (FAK) as a major protein of 110- to 130-kDa tyrosine phosphorylated in response to LPA. Tyrosine phosphorylation of paxillin by LPA was also detected.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598314     DOI: 10.1002/(SICI)1097-0215(19960301)65:5<627::AID-IJC12>3.0.CO;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor.

Authors:  Toshiyuki Kusama; Mutsuko Mukai; Masaharu Tatsuta; Yoshirou Matsumoto; Hiroyuki Nakamura; Masahiro Inoue
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Galphaq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain.

Authors:  Rafael J Rojas; Marielle E Yohe; Svetlana Gershburg; Takeharu Kawano; Tohru Kozasa; John Sondek
Journal:  J Biol Chem       Date:  2007-07-02       Impact factor: 5.157

4.  Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis.

Authors:  C Matsuda; T Ito; J Song; T Mizushima; H Tamagawa; Y Kai; Y Hamanaka; M Inoue; T Nishida; H Matsuda; Y Sawa
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

5.  Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells.

Authors:  F Imamura; M Mukai; M Ayaki; K Takemura; T Horai; K Shinkai; H Nakamura; H Akedo
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

6.  Analysis of signaling protein kinases in human colon or colorectal carcinomas.

Authors:  L L Licato; D A Brenner
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

7.  Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells.

Authors:  A Herrlich; H Daub; A Knebel; P Herrlich; A Ullrich; G Schultz; T Gudermann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.

Authors:  H Suwa; G Ohshio; T Imamura; G Watanabe; S Arii; M Imamura; S Narumiya; H Hiai; M Fukumoto
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.

Authors:  F Imamura; M Mukai; M Ayaki; H Akedo
Journal:  Jpn J Cancer Res       Date:  2000-08

10.  Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.

Authors:  Yuanfeng Zeng; Huijun Xie; Yudan Qiao; Jianmei Wang; Xiling Zhu; Guoyang He; Yuling Li; Xiaoli Ren; Feifei Wang; Li Liang; Yanqing Ding
Journal:  Cancer Sci       Date:  2015-10       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.